# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Aug 16, 2024

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2024-08-16
- Accepted by EDGAR: Aug 16, 2024, 16:04 ET
- Period: 2024-08-15
- Accession: 0000875320-24-000207
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/vrtx-20240815.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/vrtx-20240815.htm

Filed Aug 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000875320-24-000207. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.